Ontario introduces biosimilars switching policy
improving access to innovative therapies
biosimilars can significantly reshape access to innovative cancer therapies
canadian institute for health information [CIHI] publishes drug spending statistics
biosimilars are not just a cost saving opportunity but the opportunity to create a more sustainable
biosimilars. the european experience
biosimilars. past talk to action